Latest Headlines

Latest Headlines

GlaxoSmithKline pledges $330M to ramp up Relvar production, expand in U.K.

You have to hand it to GlaxoSmithKline: The company knows how to play politics in its home country. After lobbying for years for a "patent box" that would cut its taxes, the company has announced two major investments in the U.K.--and credited the patent box with both.

Hong Kong widens GSK antibiotic recall again

GlaxoSmithKline ($GSK) turned up plasticizers in two more strengths of its Augmentin antibiotic, triggering another recall in Hong Kong. After recalls of two other versions of the antibiotic, the

Vietnam to test GSK drug for contaminants

In the wake of a recall in Hong Kong, GlaxoSmithKline's ($GSK) antibiotic Augmentin is now facing testing by regulators in Vietnam. The Drug Administration of Vietnam says it will collect samples of

Hong Kong forces second GSK recall

Hong Kong isn't happy with GlaxoSmithKline ($GSK). Regulators there have ordered the drugmaker to recall an antibiotic roughly a month after they found powdered forms of the drug contaminated by

Hong Kong yanks GSK drug on phthalate levels

A GlaxoSmithKline ($GSK) antibiotic for kids has found itself under the microscope as Hong Kong authorities ordered a recall. The region's Department of Health said lab tests found